University of Michigan gets $10.7 million influx for cancer research

U-M's Comprehensive Cancer Center said today that it would conduct a five-year study of colorectal cancer and pancreatic cancer after landing the National Cancer Institute's Specialized Program in Research Excellence (SPORE) grant. Scientists from nine departments at U-M's Medical School and School of Public Health will contribute to the research project.

U-M said its scientists would place a heavy emphasis on research that could lead to technological improvements that would benefit patients.

The project will involve research on preventing colorectal cancer; developing new pancreatic cancer treatments; fostering early detection of pancreatic cancer; and improving existing pancreatic cancer treatments.

“This grant represents a major effort to bridge the basic science to the clinic," said Dean Brenner, the lead researcher for the project and a professor of internal medicine and pharmacology at the U-M Medical School and the Ann Arbor VA Healthcare System, in a news release. "You have to have very good science, but it also has to translate: How are we going to use this information to help patients? The depth of expertise at the University of Michigan allows us to pursue this work."

Contact AnnArbor.com's Nathan Bomey at (734) 623-2587 or nathanbomey@annarbor.com. You can also follow him on Twitter or subscribe to AnnArbor.com's newsletters.